The role of docosahexaenoic acid on visual evoked potentials in one kidney-one clip hypertension

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 4, 2006, Pages 488-494

  Hacioglu, Gulay ^a   Agar, Aysel ^a   Yargicoglu, Piraye ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Docosahexaenoic acid; Hypertension; Lipid peroxidation; Nitric oxide; Visual evoked potentials

Indexed keywords

DOCOSAHEXAENOIC ACID; LIPID; NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN; CONTROLLED STUDY; DRUG ACTIVITY; EVOKED VISUAL RESPONSE; HYPERTENSION; KIDNEY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; RETINA; SUPPLEMENTATION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; BRAIN; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EVOKED POTENTIALS, VISUAL; HYPERTENSION, RENOVASCULAR; KIDNEY; LIPID PEROXIDATION; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; RETINA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33746274064     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00666.x     Document Type: Article

References (53)

1. Brude IR, Drevon CA, Hjermann I et al. (1997): Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol 17: 2576-2588.
2. Celesia GG (1984): Evoked potentials techniques in the evaluation of visual function. J Clin Neurophysiol 1: 55-76.
3. Chaet MS, Garcia VF, Arya G & Ziegler MM (1994): Dietary fish oil enhances macrophage production of nitric oxide. J Surg Res 57: 65-68.
4. 2 level in spontaneously hypertensive rats. Prostag Leukotr Ess 54: 147-154.
5. Crillo D, Gonfiantini E, Degrandis D, Bongiovanni L, Robert JJ & Pinelli L (1984): Visual evoked potentials in diabetic children and adolescents. Diabetes Care 7: 273-275.
6. Cudeiro J & Rivadulla C (1999): Sight and insight - on the physiological role of nitric oxide in the visual system. Trends Neurosci 22: 109-116.
7. DeArtinano AA & Gonzalez VLM (1999): Endothelial dysfunction and hypertensive vasoconstriction. Pharmacol Res 40: 113-124.
8. Engler MM, Engler MB, Kroetz DL, Boswell KDB, Neeley E & Krassner SM (1999): The effects of a diet rich in docosahexaenoic acid on organ and vascular fatty acid composition in spontaneously hypertensive rats. Prostag Leukotr Ess 61: 289-295.
9. Evans PH (1993): Free radicals in brain metabolism and pathology. Br Med Bull 49: 577-587.
10. Frenoux JM, Prost ED, Belleville JL & Prost JL (2001): A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats. J Nutr 131: 39-45.
11. A receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol 114: 925-930.
12. Garthwaite J & Boulton CL (1995): Nitric oxide signalling in the central nervous system. Annu Rev Physiol 57: 683-706.
13. Givre SJ, Schroeder CE & Arezzo JC (1994): Contribution of extrastriate area V4 to the surface-recorded flash VEP in the awake macaque. Vision Res 34: 415-438.
14. Glozman S, Green P & Yavin E (1998): Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischaemic stress. J Neurochem 70: 2484-2491.
15. GoldsteiA IM, Ostwald P & Roth S (1996): Nitric oxide: a review of its role in retinal function and disease. Vision Res 36: 2979-2994.
16. Hacioglu G, Agar A, Ozkaya G, Yargicoglu P & Gumuslu S (2002): The effect of different hypertension models on visual evoked potentials. Int J Neurosci 112: 1321-1335.
17. Halliday AM (1976): Visual evoked responses in optic nerve disease. Trans Ophtalmol Soc UK 96: 372-376.
18. Hedge LG, Srivastavo P, Kumari R & Dikshit M (1998): Alterations in the vasoreactivity of hypertensive rat aortic rings: Role of nitric oxide and superoxide radicals. Clin Exp Hypertens 20: 885-901.
19. 1,2 Neurotoxicol Teratol 17: 645-656.
20. Hertzler BE, Boyes WC, Creason J & Dyer RS (1988): Temperature-dependent changes in visual evoked potentials of rats. Electroenceph Clin Neurophysiol 70: 137-154.
21. Hooper L, Thompson RL, Harrison RA et al. (2004): Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 18 (4): CD003177.
22. Hutri-Kahönen N, Porsti I, Wu X, Tolvanen JP, Sallinen K & Kahönen M (1997): Arterial responses to bradykinin after ramipril therapy in experimental hypertension. Pharmacol Toxicol 81: 190-196.
23. Kashii S, Mandai M, Kikuchi M et al. (1996): Dual actions of nitric oxide in N-methyl-D-aspartate reseptor-mediated neurotoxicity in cultured retinal neurons. Brain Res 711: 93-101.
24. Khair-El-Din T, Sicher SC, Vazquez MA et al. (1996): Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J Exp Med 183: 1241-1246.
25. Kraut MA, Arezzo JC & Vaughan HGJ (1985): Intracortical generators of the flash VEP in monkeys. Electroenceph Clin Neurophysiol 62: 300-312.
26. Lawson DL, Mehta JL, Saldeen K, Mehta P & Saldeen TG (1991): Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids 4: 217-223.
27. Lehman DM & Harrison JM (2002): Flash evoked potentials in the hypomyelinated mutant mouse shiverer. Doc Ophthalmol 104: 83-95.
28. Liu J, Yeo HC, Doniger SJ & Ames BN (1997): Assay of aldehydes from lipid peroxidation: Gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal Biochem 245: 161-166.
29. Lowry OH, Rosenbrough NJ, Far AL & Randel RJ (1951): Protein measurement with folin-phenol reagent. J Biol Chem 193: 265-275.
30. Lu CY, Penfield JG, Khair-el-Din TA et al. (1998): Docosahexaenoic acid, a constituent of fetal and neonatal serum, inhibits nitric oxide production by murine macrophages stimulated by IFN gamma plus LPS, or by IFN gamma plus Listeria monocytogenes. J Reprod Immunol 38: 31-53.
31. Minami M, Kimura S, Endo T et al. (1997): Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 58: 1123-1129.
32. Mori TA, Bao DQ, Burke V, Puddey IB & Beilin LJ (1999): Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertens 34: 253-260.
33. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD & Beilin LJ (2003): Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Rad Bio Med 35: 772-781.
34. Morris MC (1994): Dietary fats and blood pressure. J Cardiovasc Risk 1: 21-30.
35. Munzel T, Heitzer T & Harrison DG (1997): The physiology and pathophysiology of the nitric oxide/superoxide system. Herz 22: 158-172.
36. Nenseter MS & Drevon CA (1996): Dietary polyunsaturates and peroxidation of low density lipoprotein. Curr Opin Lipidol 7: 8-13.
37. Ohata T, Fukuda K, Takahashi M, Sugimura T & Wakabayashi K (1997): Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by ù-3 polyunsaturated fatty acids. Jpn J Cancer Res 88: 234-237.
38. Ohta T, Arai Y & Takitani S (1986): Fluorometric determination of nitrite with 4-hydroxycoumarin. Anal Chem 58: 3132-3135.
39. Ohta Y, Yamasaki T, Niwa T, Niimi K, Majima Y & Ishiguro I (1996): Role of catalase in retinal antioxidant defence system: Its comparative study among rabbits, guinea pigs and rats. Ophthalmic Res 28: 236-242.
40. Oku H, Yamaguchi H, Sugiyama T, Kojima S, Ota M & Azuma I (1997): Retinal toxicity of nitric oxide released by administration of a nitric oxide donor in the albino rabbit. Invest Ophthalmol Vis Sci 38: 2540-2544.
41. Prisco D, Paniccia R, Bandinelli B et al. (1998): Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 91: 105-112.
42. Sacks FM, Hebert P, Appel LJ et al. (1994): The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. J Hypertens 12 (Suppl): 23-31.
43. San Giovanni JP & Chew EY (2005): The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24: 87-138.
44. Sarsilmaz M, Songur A, Ozyurt H et al. (2003): Potential role of dietary ù-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostag Leukotr Ess 69: 253-259.
45. Sasaki T, Kanke Y, Kudoh K et al. (2000): Dietary n-3 polyunsaturated fatty acid and status of immunocompetent cells involved in innate immunity in female rats. Ann Nutr Metab 44: 38-42.
46. Schmidt HH & Walter U (1994): NO at work. Cell 78: 919-925.
47. Schulz JB, Russell TM & Beal F (1995): Role of nitric oxide in neurodegenerative diseases. Curr Opin Neurol 8: 480-486.
48. Song JH & Miyazawa T (2001): Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil. Atherosclerosis 155: 9-18.
49. Tandon OP & Ram D (1997): Visual evoked potentials in primary hypertension. Ind J Physiol Pharmacol 41: 154-158.
50. Wasowicz W, Jean N & Peratz A (1993): Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum. Importance of extraction pH and influence of sample, preservation and storage. Clin Chem 39: 2522-2526.
51. Wright CE, Harding GF & Orwin A (1986): The flash and pattern VEP as diagnostic indicator of dementia. Doc Ophthalmol 62: 89-96.
52. Xiao YF, Ke Q, Chen Y, Morgan JP & Leaf A (2004): Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells. Biochem Biophys Res Commun 321 (1): 116-123.
53. Yu H, Rakugi H, Higaki J, Morishita R, Mikami H & Ogihara T (1993): The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one-clip hypertensive rats. J Hypertens 11: 1347-1355.